权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Tie Tek Modulation of Cardiac Development

心脏发育的 Tie Tek 调节

基本信息

批准号：
9483827
负责人：
H Scott Baldwin
金额：
$ 5.45万
依托单位：
VANDERBILT UNIVERSITY MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-06-01 至 2018-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9483827
关键词：
Affect Alanine Angiopoietin-2 Angiopoietins Animals Aorta Atherosclerosis Attenuated Bioinformatics Cardiac Cardiac development Cardiovascular system Cell Line Cell Proliferation Cell physiology Cell surface Cells Complementary DNA Data Defect Deletion Mutation Development Dorsal EGF gene Embryo Endocardium Endothelial Cells Event Extracellular Domain Foundations Growth Heart Immunoglobulins In Vitro Inflammatory Response Knock-in Mouse Knowledge Ligands LoxP-flanked allele Lymphatic Lysine Mediating Morphogenesis Morphology Mus Phenotype Phenylalanine Phosphorylation Play Point Mutation Protein Tyrosine Kinase RNA Receptor Protein-Tyrosine Kinases Role Series Signal Pathway Signal Transduction Signal Transduction Pathway Stretching TIE-2 Receptor Time Tyrosine Tyrosine Kinase Domain Vascular Endothelial Growth Factors angiogenesis aortic valve attenuation cardiogenesis congenital heart disorder experimental study genetic analysis hemodynamics in utero in vivo migration mutant novel novel therapeutic intervention public health relevance receptor recombinase-mediated cassette exchange response to injury semilunar valve shear stress transcriptome sequencing

项目摘要

DESCRIPTION (provided by applicant): Tie1 and Tek (also known as Tie2) are endothelial protein receptor tyrosine kinases (RTKs). Along with the vascular endothelial growth factor (VEGF) receptor, these are the only known endothelial cell-specific RTKs. Due to embryonic lethality of panendotheilal deletion of either Tie 1 or Tie2 the exact roles and mechanisms of Tie1 or Tie2 in regulating cardiac development has not been clearly delineated. Furthermore the ligand(s) for Tie1 or the targets of Tie1 activation have not been identified. We hypothesize that in the cardiovascular system Tie1 is not only an inhibitory co-receptor for Tie2 activation, but also capable of signaling autonomously of Tie2. We therefore propose to: 1) Determine the unique functions of Tie1 and Tie2 signaling during early and late stages of cardiac development in vivo: Recently generated mice harboring a floxed allele of Tie1 or Tie2 will be used in conjunction with a novel early endocardial specific (Nfatc1Cre) or a later valvular endocardial Cre line (Nfatc1enCre) to produce stage specific cardiac deletion of Tie1 and Tie2 throughout the continuum of heart development in utero. Morphological and functional analysis will be used to characterize the unique phenotype that results from cardiac specific RTK attenuation. 2) Define the specific Tie1-Tie2 interactions that are required for normal cardiac morphogenesis at both early and late stages of heart formation in vivo. Recombinase mediated cassette exchange (RMCE) will be used to evaluate potential critical domains of Tie1-Tie2 interaction specifically in the endocardium. We will generate a series of cDNA "knock-in" mice lacking the extracellular domain (ECD), intracellular domain (ICD) as well as point mutations in critical tyrosine kinase domains in the cytoplasmic region of Tie1 (tyrosine to phenylalanine/Y1113F and lysine to alanine/K866A). These animals will be crossed to endocardial specific Cre lines and evaluated for specific defects in cardiac development. 3) Delineate down-stream targets of Tie1 activation in the cardiovascular system. In the absence of a known ligand for Tie1 activation, hemodynamic activation of Tie1 signaling will be used to evaluate the effect of defined deletion / mutations of Tie1. Immortalized endocardial cell lines derived from the conditional Tie1 mutants will be exposed to altered shear stress, turbulence and stretch and evaluated for alterations in previously described signal transduction pathways attributed to Tie activation. The most informative Tie1 mutant animals will be used for RNA-Seq and bioinformatic analysis for construction of signaling networks that will define a unique singling signature for Tie1 and help delineate endothelial cell autonomous and non-autonomous signaling pathways in the heart.

描述（由申请人提供）：Tie1和Tek（也称为Tie2）是内皮蛋白受体酪氨酸激酶（rtk）。与血管内皮生长因子（VEGF）受体一起，这些是唯一已知的内皮细胞特异性rtk。由于Tie1或Tie2的全内皮缺失会导致胚胎死亡，因此Tie1或Tie2在调节心脏发育中的确切作用和机制尚不清楚。此外，Tie1的配体或Tie1活化的靶标尚未确定。我们推测，在心血管系统中，Tie1不仅是Tie2激活的抑制共受体，而且还能够自主地发出Tie2的信号。因此，我们建议：1)确定Tie1和Tie2信号在体内心脏发育早期和晚期的独特功能：新近生成的小鼠携带Tie1或Tie2的固定等位基因，将与新的早期心内膜特异性（Nfatc1Cre）或晚期瓣膜心内膜Cre系（Nfatc1enCre）结合使用，在子宫内心脏发育的整个连续体中产生阶段特异性的Tie1和Tie2的心脏缺失。形态学和功能分析将用于表征心脏特异性RTK衰减导致的独特表型。2)明确体内心脏形成早期和晚期正常心脏形态发生所需的特定Tie1-Tie2相互作用。重组酶介导的盒式交换（RMCE）将用于评估Tie1-Tie2相互作用的潜在关键区域，特别是在